Clinical Trials for ImmuneOncia Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: ImmuneOncia Therapeutics

Clinical Trials (3)

NCT06365840
A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor
PHASE2Recruiting
30 participants
Started: Jan 13, 2025 · Completed: Aug 31, 2029
2 conditions1 sponsor1 location
NCT05276310
A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy
PHASE1Recruiting
62 participants
Started: Jun 2, 2022 · Completed: Aug 30, 2029
1 condition1 sponsor3 locations
NCT04414163
A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
PHASE2Active, not recruiting
23 participants
Started: Oct 27, 2020 · Completed: Feb 28, 2026
2 conditions1 sponsor5 locations